ArticleAnnals of hematology2026

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Salvatore Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.